Believe the Data

被引：14

作者：

Drazen, Jeffrey M.

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 12期

关键词：

D O I：

10.1056/NEJMe1207121

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1152 / 1153

页数：2

共 8 条

[1] Clinical trial registration: A statement from the International Committee of Medical Journal Editors [J].

De Angelis, C ;

Drazen, JM ;

Frizelle, FA ;

Haug, C ;

Hoey, J ;

Horton, R ;

Kotzin, S ;

Laine, C ;

Marusic, A ;

Overbeke, AJPM ;

Schroeder, TV ;

Sox, HC ;

Van der Weyden, MB .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (12) :1250-1251

[2] Toward More Uniform Conflict Disclosures - The Updated ICMJE Conflict of Interest Reporting Form [J].

Drazen, Jeffrey M. ;

de Leeuw, Peter W. ;

Laine, Christine ;

Mulrow, Cynthia ;

DeAngelis, Catherine D. ;

Frizelle, Frank A. ;

Godlee, Fiona ;

Haug, Charlotte ;

Hebert, Paul C. ;

James, Astrid ;

Kotzin, Sheldon ;

Marusic, Ana ;

Reyes, Humberto ;

Rosenberg, Jacob ;

Sahni, Peush ;

Van Der Weyden, Martin B. ;

Zhaori, Getu .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (02) :188-189

[3] GlaxoSmithKline faces US lawsuit over concealment of trial results [J].

Dyer, O .

BRITISH MEDICAL JOURNAL, 2004, 328 (7453) :1395-1395

[4]

Frost P, 2012, CHICAGO TRIBUNE

[5]

Harris G, 2004, NY TIMES 1121

[6] A Randomized Study of How Physicians Interpret Research Funding Disclosures [J].

Kesselheim, Aaron S. ;

Robertson, Christopher T. ;

Myers, Jessica A. ;

Rose, Susannah L. ;

Gillet, Victoria ;

Ross, Kathryn M. ;

Glynn, Robert J. ;

Joffe, Steven ;

Avorn, Jerry .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (12) :1119-1127

[7] Merck pays $1bn penalty in relation to promotion of rofecoxib [J].

Tanne, Janice Hopkins .

BRITISH MEDICAL JOURNAL, 2011, 343

[8] GSK is accused of trying to suppress editorial on rosiglitazone [J].

Tanne, Janice Hopkins .

BRITISH MEDICAL JOURNAL, 2010, 340

← 1 →